Showing results (21-30 of 70) with videos related to

Sort By:
Pageof 7
Oncoimmunology|January 12, 2023
Daratumumab induces cell-mediated cytotoxicity of primary effusion lymphoma and is active against refractory diseasePrabha Shrestha, Yana Astter, David A Davis, et al.
British Journal of Haematology|February 25, 2009
Variable CD52 expression in mature T cell and NK cell malignancies: implications for alemtuzumab therapyLiuyan Jiang, Constance M Yuan, Julia Hubacheck, et al.
Cytometry. Part B, Clinical Cytometry|September 28, 2010
Variables affecting the quantitation of CD22 in neoplastic B cellsGregory A Jasper, Indu Arun, David Venzon, et al.
American Journal of Clinical Pathology|May 17, 2011
Flow cytometric immunophenotypic assessment of T-cell clonality by Vβ repertoire analysis: detection of T-cell clonality at diagnosis and monitoring of minimal residual disease following therapyPrashant Tembhare, Constance M Yuan, Liqiang Xi, et al.
NPJ Precision Oncology|July 18, 2025
Molecular analysis of bilateral T-cell vitreoretinal lymphomaMatias Soifer, Sonny Caplash, Rajesh C Rao, et al.
Leukemia & Lymphoma|March 18, 2021
Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphomaJayalakshmi Balakrishna, Neil Basumallik, Robert Matulonis, et al.
Cytometry. Part B, Clinical Cytometry|May 12, 2019
Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell LeukemiaDalia A Salem, Drake Scott, Catharine S McCoy, et al.
Cytometry. Part B, Clinical Cytometry|April 9, 2026
To fret over FRET: Unintended fluorescence energy transfer artifacts and their implications for flow cytometry panel design and interpretation as highlighted by TRBC1/2 assaysHao-Wei Wang, Dana Delgado Colon, Kyle Murphy, et al.
American Journal of Clinical Pathology|November 15, 2013
Quantification of expression of antigens targeted by antibody-based therapy in chronic lymphocytic leukemiaPrashant R Tembhare, Gerald Marti, Adrian Wiestner, et al.
Molecular Therapy Oncolytics|December 25, 2018
Preclinical Development of Bivalent Chimeric Antigen Receptors Targeting Both CD19 and CD22Haiying Qin, Sneha Ramakrishna, Sang Nguyen, et al.
Pageof 7